MarketInOut Stock Screener Log In | Sign Up
 

Actinium Pharmaceuticals Inc

IEX • Healthcare • Biotechnology • Quote as of 09/11/2026
Actinium Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization44.02 mln
Float31.19 mln
Earnings Date11/23/2026

EPS

0.35
Marginal

P / E

4.00
Deeply undervalued

Piotroski F-Score

3 / 9
Below average

1-Year Forecast

3.50
Transformational upside

Relative Strength

100 / 100
Top performer

Debt / Equity

0.04
Debt-free

Business Description

Actinium Pharmaceuticals is a New York-based biotech company focused on developing radiation-based treatments for patients with cancer and other blood disorders who have not responded to standard therapies. Its pipeline includes several candidates targeting conditions such as acute myeloid leukemia, sickle cell disease, and prostate cancer, with approaches ranging from bone marrow transplant preparation to improving the effectiveness of CAR-T cell therapy. The company also works alongside the National Cancer Institute to advance its research and is exploring further treatments for solid tumors.

Key Fundamentals

EPS0.35
P/E4.00
ROE77.20
RPS1.12
ROIC337
ROA22.04
EBITDA, mln10.43
EV / EBITDA-0.33
EV / EBIT-0.36
Revenue, mln35.09
EV / Revenue0.25

Financial Strength

Altman Z-Score-8.92
Piotroski F-Score 3 / 9
Price to Graham Number0.36
1-Year Target Price3.50
Short Ratio3.80
Short % of Float2.15

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 33.33% 100 / 100   
1 Month 68.88% 100 / 100   
2 Months 25% 92 / 100   
6 Months 22.81% 79 / 100   
1 Year -14.63% 31 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us